Drawing for ALERE

USPTO serial 77837309

ALERE

Reviewed by CopyMark Law Group

Reg. 4760465Status 710
Filing date
Status date
Registration date
Jun 23, 2015
Examiner
RICHARDS, SUSAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ALERE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations for scientific purposes; reagents for chemical analysis; chemical test paper; protein arrays and nucleotide arrays for scientific and medical research; diagnostic preparations for clinical or medical laboratory use; diagnostic preparations for scientific or research use; laboratory chemicals, namely, antibodies for use in scientific and medical research; laboratory chemicals, namely, fluorescent compound preparations for use in protein labeling in connection with scientific and medical research; laboratory chemicals, namely, gold liquid colloid solutions or sols for use in protein labeling in connection with scientific and medical research; assays for research purposes; chemicals, namely, buffer solutions used in analytical chemistry; laboratory chemicals, namely, control fluids for use in scientific and medical research; reagents for research purposes, namely, control reagents for use with scientific apparatus and instruments for use in scientific and medical researchSECTION 8 - CANCELLED—
005Chemical reagents for medical purposes; medical diagnostic reagents; reagents for medical use; chemical and biological antigens for medical diagnostic use; clinical medical reagents; pharmaceutical preparations for clinical research and genetic testing, namely, identifying birth defects and pregnancy disorders; diagnostic test kits consisting primarily of medical diagnostic chemicals and reagents; ovulation test kits; pregnancy test kits for home and medical use; cancer diagnostic test kits comprised primarily of reagents and assays for home and medical use for detecting cancers; medical diagnostic test kits comprised primarily of reagents and assays for testing bacterial vaginosis; medical diagnostic preparations and medical diagnostic reagents for home use; medical diagnostic test strips for home and medical use; medical diagnostic reagents and assays for testing bodily fluids; drug and alcohol testing kits for home and medical use comprised primarily of medical diagnostic reagents and assays for testing bodily fluids; drug testing device in the nature of drug testing cups containing a test strip for testing the presence of drugs in bodily fluids other than for medical purposesSECTION 8 - CANCELLED—
009Measuring devices, namely, fluorometers; electronic optical and electrochemical readers for use with medical diagnostic test kits; laboratory equipment, namely, culture tubes, test tubes, storage tubes, tube caps, pipettes, hand-operated laboratory presses for processing samples in preparation for analysis, and laboratory racks for containers for storing samples; laboratory equipment, namely, assay diagnostic slides; computer hardware; computer software that may be downloaded from computer networks for providing access to medical records; computer software for managing medical diagnostic test information; computer software in the healthcare field for managing data relating to the admission, treatment, discharge and invoicing of patients; computer software for providing access to medical case records via computer networks; computer software for transmitting electronic messages and data over computer networks in between different computer systems; computer software for scheduling medical appointments and appointments for use of medical equipment; computer software for generating medical staff duty rosters; computer software for managing data relating to medical research, laboratory test results and medical consultations; computer software for the extraction and analysis of statistical informationSECTION 8 - CANCELLED—
010Blood testing apparatus; electrochemical sensors for determination or analysis of analyte concentrates in blood and body fluids for medical purposes; medical diagnostic apparatus for testing the presence of alcohol in breath; medical diagnostic apparatus for testing the presence of drugs in body fluids, hair and breath; medical apparatus for detecting and measuring the level of drugs and alcohol in body fluids; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; medical apparatus and units for introducing pharmaceutical preparations into the body and for measuring drug dosages; medical apparatus and instruments for pregnancy testing, fertility monitoring, diagnosing and monitoring cardiovascular disease and detecting infectious diseases; medical diagnostic apparatus for use in monitoring and reporting data such as weight, blood pressure, pregnancy, ovulation, blood glucose levels, blood chemistry data, heart rate, EKG, coagulation time, peak flow and respiratory function in patients with diseases such as asthma, diabetes, obesity, hypertension, infectious diseases, cardio vascular disease, renal disease, cancer, and chronic obstructive pulmonary disease; medical instruments, namely, lances, lancets, lancing devices, syringes, hypodermic needlesSECTION 8 - CANCELLED—
042Medical and scientific research; research and development in the field of pharmaceuticals and biotechnology, namely, in the field of antibodies and biochemical assays for diagnostic purposes; medical laboratories; medical and scientific research, namely, conducting clinical trials; IT consulting services; consulting services in the field of medical and healthcare technology; medical testing of blood; data mining; consulting in the field of product safety testing relating to medical diagnostic apparatus and instruments; providing an interactive website featuring technology enabling medical device users to exchange information with healthcare providers via a global computer networkSECTION 8 - CANCELLED—
044Healthcare services; medical services; medical diagnostic testing, monitoring and reporting services; providing medical information; consulting and advisory services in the field of medical information; consulting services in the field of health; surgical services; blood bank services; providing health information; providing a website featuring medical information; providing a website featuring health and nutritional information and providing dietary and nutritional guidance; providing a website featuring medical information in the nature of health test results and health risk assessments; providing healthcare information via the Internet; medical services and medical physical evaluation services, namely, providing health screening services, health risk appraisals, personal health profiles, and health assessments for consumers, healthcare professionals, healthcare institutions; consulting in the field of medical testing for diagnostic and treatment purposesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 24, 2021C8..CANCELLED SEC. 8 (6-YR)—
Jun 23, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 11, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 25, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 4, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 1, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 23, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 22, 2015SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 21, 2015CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 28, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 27, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 27, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 6, 2014CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Sep 3, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 28, 2014IUAFUSE AMENDMENT FILED—
Aug 28, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 14, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 13, 2014EX5GSOU EXTENSION 5 GRANTED—
Feb 3, 2014EXT5SOU EXTENSION 5 FILED—
Feb 3, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 25, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 24, 2013EX4GSOU EXTENSION 4 GRANTED—
Jul 22, 2013EXT4SOU EXTENSION 4 FILED—
Jul 22, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 24, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 23, 2013EX3GSOU EXTENSION 3 GRANTED—
Jan 9, 2013EXT3SOU EXTENSION 3 FILED—
Jan 9, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 17, 2012EX2GSOU EXTENSION 2 GRANTED—
Jul 13, 2012EXT2SOU EXTENSION 2 FILED—
Jul 13, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 28, 2012EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 27, 2012EX1GSOU EXTENSION 1 GRANTED—
Feb 17, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 24, 2012EXT1SOU EXTENSION 1 FILED—
Jan 24, 2012EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 6, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 20, 2011CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jul 19, 2011APETASSIGNED TO PETITION STAFF—
Jul 13, 2011EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jul 12, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 12, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 9, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 2, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 1, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 1, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 1, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 1, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 18, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2011ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 1, 2011PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 18, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 16, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 14, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2011ALIEASSIGNED TO LIE—
Feb 2, 2011ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 15, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Aug 4, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 4, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 4, 2010CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 16, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 28, 2010ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jan 26, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 26, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 27, 2009DOCKASSIGNED TO EXAMINER—
Oct 8, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 7, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 2, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance